Aptevo to Showcase Multispecific Platform at SITC 2026
Aptevo Therapeutics will present at the Society for Immunotherapy of Cancer to highlight its CD40-directed multispecific portfolio and platform technology designed to coordinate in…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Aptevo Therapeutics will present at the Society for Immunotherapy of Cancer to highlight its CD40-directed multispecific portfolio and platform technology designed to coordinate in…
Pulse Biosciences announced a commercial and clinical partnership with the Clayman Thyroid Center to treat benign thyroid nodules, advancing market development for its nanosecond p…
Compass, Inc. appoints Google veteran Sissie Hsiao to its Board of Directors and appoints Frank Martell as Lead Independent Director following the resignation of Charles Phillips.
XTI Aerospace appointed Unusual Machines CEO Dr. Allan Evans as Chairman of its board, marking a leadership change for its drone division. This appointment strengthens company gove…
Biopharma veteran Michael P. Bailey will assume the role of President and CEO on January 1, 2027, to lead the company's commercial growth and pipeline strategy.
Polar Power Inc. appointed Chris Mayer as Co-CEO to drive corporate strategy and financial growth, aligning with the company's efforts to expand its telecom and defense market pres…
Intelligent Bio Solutions Inc. filed an exhibit (3.1) announcing the adoption of a Second Amended and Restated Bylaws on October 12, 2026. This operational update was filed with th…
Thomas Freeburg has agreed to serve as Chief Financial Officer, starting in September 2026, overseeing SEC filings and financial operations.
Merck Board announces Paul J. Diaz will join the board effective Nov. 1, 2026, standing for election in May 2027. This appointment expands the board to 14 members, adding expertise…
MetaVia announces Dr. Sarah Browne as Chief Medical Officer to advance its portfolio of cardiometabolic drugs, including Phase 3 candidate DA-1726, stimulating investor interest in…
M Evo Global Acquisition Corp II has appointed Richard Majlinder as a director, following his execution of a Board Participation Agreement.
Adia Med Inc. and its CEO Larry Powalisz signed a paid-in-full acknowledgment on Oct. 9 to settle outstanding accrued interest and principal under a $1M revolver dated June 30, 202…
Zoetis Inc. announced the appointment of industry veteran Iris Knobloch to its board of directors effective December 1, 2026. This leadership addition enhances the board's strategy…
Mueller Water Products and Chief Financial Officer Melissa Rasmussen have agreed on a transition plan, as reported in a recent filing. The agreement will have minor implications fo…
Avery Dennison named Helen Sheirbon to lead its Solutions Group starting November 2026, aiming to boost digital innovation and operational excellence.
Enovix reported $11.0 million in Q3 revenue, up 38% year-over-year. The company realigned its leadership team to focus on drone and defense growth while investing to expand manufac…
Bausch + Lomb Corp and Executive Brenton L. Saunders have entered into a separation agreement aimed at resolving all compensation entitlements. The agreement is subject to binding …
Vistagen Therapeutics, Inc. adopted an Executive Severance Plan effective October 7, 2026, to provide key employees with severance payments and other benefits upon resignation or t…
Moleculin Biotech Inc. adopted a 2024 Stock Plan to attract and retain employees, effective as of October 24, 2024. This corporate governance action is aimed at incentivizing staff…
IMPACT BIOMEDICAL INC. appointed Tim Terpstra as a director. This brings experienced executive leadership to the board to oversee company operations.